Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8

specific

Stage IB includes: (T1a, N0, M0, G2); (T1b, N0, M0, G1-2); (T1b, N0, M0, GX). T1a: Tumor invades the lamina propria or muscularis mucosae. T1b: Tumor invades the submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well-differentiated. GX: Grade cannot be assessed. G2: Moderately differentiated. (AJCC 8th ed.)

6

Centers

8

Active Trials

—

Cancer Funding

Top Centers for Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8(6)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
High-Volume Research Center
73.3
2
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
High-Volume Research Center
73.3
3
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
Active Research Program
50.8
4
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
50.8
5
University of Illinois Cancer CenterChicago, IL
Active Research Program
50.8
6
Boston University Cancer CenterBoston, MA
Active Research Program
50.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →